Skip to main content

Table 1 Baseline demographic and clinical characteristics of the study cohort

From: Genetic architecture of cardiometabolic risks in people living with HIV

Variable PLWHEAa
n = 3095 (%)
PLWHAAb
n = 3189 (%)
Total
N = 6284 (%)
p valuec
Age 53.36 ± 9.70 53.18 ± 10.70 53.27 ± 10.22 0.49
Gender     < 0.0001
 Male 2763 (89.3) 2199 (69.0) 4962 (79.0)  
 Female 332 (10.7) 990 (31.0) 1322 (21.0)  
Site     < 0.0001
 University of Alabama 744 (24.0) 882 (27.7) 1626 (25.9)  
 Johns Hopkins 135 (4.4) 845 (26.5) 980 (15.6)  
 University of Washington 623 (20.1) 261 (8.2) 884 (14.1)  
 University of California San Diego 640 (20.7) 187 (5.9) 827 (13.2)  
 Case Western Reserve University 314 (10.1) 494 (15.5) 808 (12.9)  
 University of North Carolina 161 (5.2) 368 (11.5) 529 (8.4)  
 Fenway 309 (10.0) 45 (1.4) 354 (5.6)  
 University of California San Francisco 169 (5.5) 107 (3.4) 276 (4.4)  
Type 2 diabetesd 388 (12.5) 676 (21.2) 1064 (16.9) < 0.0001
Myocardial infarctione 53 (1.7) 64 (2.0) 117 (1.9) < 0.39
CD4 countsc 399 ± 283.5 331 ± 277.3 364 ± 282.4 < 0.0001
Presence of antiretroviral therapy 2841 (91.8) 2823 (88.5) 5664 (90.1) < 0.0001
  1. aPLWHEA, European American sub-cohort of people living with HIV. bPLWHAA, African American sub-cohort of people living with HIV. cThe p values were calculated using a t-test. dDuring study follow-up. eAt baseline